Antibiotic use in Dutch hospitals 1991-1996

被引:46
作者
Janknegt, R
Lashof, AO
Gould, IM
van der Meer, JWM
机构
[1] Maasland Ziekenhuis, Dept Clin Pharm & Toxicol, NL-6130 MB Sittard, Netherlands
[2] Univ Nijmegen Hosp, NL-6500 HB Nijmegen, Netherlands
[3] Aberdeen Royal Hosp, Aberdeen, Scotland
关键词
D O I
10.1093/jac/45.2.251
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The use of antibiotics in Dutch hospitals between 1991 and 1996 was investigated. A total of 54 hospitals responded to the enquiry, representing over 70% of all hospital beds in The Netherlands. The use of antibiotics in Dutch hospitals, expressed as defined daily doses (DDD) per hundred bed days, gradually increased from 37.2 DDD per 100 bed days in 1991 to 42.5 DDD per 100 bed days in 1996. The antibiotic that showed the largest increase in use was co-amoxiclav. Its use increased more than three-fold from 3.93 DDD per 100 bed days in 1991 to 12.5 DDD per 100 bed days in 1996. The increase in use of co-amoxiclav exceeded the increase in total antibiotic consumption. The use of cephalosporins remained fairly constant during the study period, but there were changes in the relative use of the different cephalosporin groups. The use of earlier cephalosporins gradually decreased, whereas the use of the more recently developed cephalosporins increased between 1991 and 1996. Ciprofloxacin and norfloxacin were the most commonly used fluoroquinolones throughout the study period. The use of ofloxacin increased significantly between 1991 and 1996, approaching the levels of use of ciprofloxacin and norfloxacin. There may be complex reasons for the increases, which need further analysis, but they mirror those few data available from elsewhere in the world. Possible explanations include more intensive treatment to expedite patient discharges, sicker patients with more serious infections and more resistant organisms.
引用
收藏
页码:251 / 256
页数:6
相关论文
共 9 条
[1]  
Gould IM, 1996, J ANTIMICROB CHEMOTH, V38, P895
[2]   THE MANAGEMENT OF INFECTIONS AND ANTIBIOTIC-THERAPY - A EUROPEAN SURVEY [J].
HALLS, GA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (06) :985-1000
[3]   THE DEFINED DAILY DOSE PER 100 BED-DAYS AS A UNIT OF COMPARISON AND A PARAMETER FOR STUDYING ANTI-MICROBIAL DRUG-USE IN A UNIVERSITY HOSPITAL - A RETROSPECTIVE STUDY OF THE EFFECTS OF GUIDELINES AND AUDIT ON ANTI-MICROBIAL DRUG-USE [J].
HEKSTER, YA ;
VREE, TB ;
GORIS, RJA ;
BOEREMA, JBJ .
JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1982, 7 (04) :251-260
[4]   ANTIMICROBIAL DRUG-USE IN HOSPITALS IN THE NETHERLANDS, GERMANY AND BELGIUM [J].
JANKNEGT, R ;
WIJNANDS, WJA ;
CAPRASSE, M ;
BRANDENBURG, W ;
SCHUITENMAKER, MG ;
STOBBERINGH, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (11) :832-838
[5]   ANTIMICROBIAL PROPHYLAXIS IN BOWEL SURGERY IN THE NETHERLANDS [J].
JANKNEGT, R ;
WIJNANDS, WJA ;
STOBBERINGH, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (07) :596-600
[6]  
JANKNEGT R, 1994, ZIEKENHUISFARMACIE, V10, P115
[7]  
MARTINI M, 1990, PROGR CLIN PHARM, P220
[8]   Application of the ATC/DDD methodology to monitor antibiotic drug use [J].
Natsch, S ;
Hekster, YA ;
de Jong, R ;
Heerdink, ER ;
Herings, RMC ;
van der Meer, JWM .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (01) :20-24
[9]  
WALLENIUS K, 1990, PROGR CLIN PHARM, P305